teva-english-logo-gray-web-5-1
Photo: Courtesy of Teva
16 March 2017Americas

Teva and Actavis taken to court over acne drug

Dow Pharmaceutical Sciences and Valeant Pharmaceuticals have sued Teva and its subsidiary Actavis for patent infringement of Onexton (clindamycin phosphate and benzoyl peroxide), a treatment for acne.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk